Compare SHIM & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHIM | CSBR |
|---|---|---|
| Founded | 1990 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.5M | 90.0M |
| IPO Year | 2023 | 1986 |
| Metric | SHIM | CSBR |
|---|---|---|
| Price | $2.69 | $6.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 39.5K | 9.2K |
| Earning Date | 11-13-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | ★ $495,984,000.00 | $56,878,000.00 |
| Revenue This Year | $6.91 | $7.31 |
| Revenue Next Year | $13.03 | $12.01 |
| P/E Ratio | ★ N/A | $29.53 |
| Revenue Growth | N/A | ★ 10.11 |
| 52 Week Low | $1.30 | $4.61 |
| 52 Week High | $3.50 | $11.99 |
| Indicator | SHIM | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 60.74 | 59.79 |
| Support Level | $2.61 | $6.16 |
| Resistance Level | $2.73 | $6.43 |
| Average True Range (ATR) | 0.20 | 0.24 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 89.70 | 79.04 |
Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.